Pía Garat

Pía Garat is a co-founder of Eolo Pharma, a biotechnology company based in Uruguay. She has been instrumental in the development of SANA, a groundbreaking medication designed to combat obesity, which has recently shown promising results in early clinical trials. Under her leadership, Eolo Pharma aims to provide innovative treatments that address obesity while emphasizing the need for behavioral changes in patients. Garat's work is celebrated as a significant milestone for Uruguay, marking the first time a drug of this kind has been developed entirely within the country.